Drugs / C-11 choline PET tracer
C-11 choline PET tracer
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03404648 | Nov 2017 → Jan 2020 | prostate adenocarcinoma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-11 choline PET tracer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03404648 ↗ |
| Modality | Diagnostic / imaging agent | “C-11 choline PET tracer” NCT03404648 ↗ |
| Route | Intravenous | “intravenous administration while patient is lying on the table” NCT03404648 ↗ |